These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 3119699)
21. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery. Barbarino A; De Marinis L; Maira G; Menini E; Anile C J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421 [TBL] [Abstract][Full Text] [Related]
22. The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma. Marrs RP; Bertolli SJ; Kletzky OA Am J Obstet Gynecol; 1980 Nov; 138(6):620-5. PubMed ID: 6776812 [TBL] [Abstract][Full Text] [Related]
23. Prolactin secretion in acromegalic patients before and after selective adenomectomy. Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of thyrotropin releasing hormone test in 129 patients with suspected tumoral hyperprolactinemia. Smircić-Duvnjak L; Vizner B; Korsić M; Sekso M; Berković M Coll Antropol; 2002 Dec; 26(2):635-40. PubMed ID: 12528293 [TBL] [Abstract][Full Text] [Related]
25. Different prolactin, thyrotropin, and thyroxine responses after prolonged intermittent or continuous infusions of thyrotropin-releasing hormone in rhesus monkeys. Pavasuthipaisit K; Norman RL; Ellinwood WE; Oyama TT; Baughman WL; Spies HG J Clin Endocrinol Metab; 1983 Mar; 56(3):541-8. PubMed ID: 6401761 [TBL] [Abstract][Full Text] [Related]
26. In vivo effects of progestins on prolactin secretion. Sitruk-Ware R; Varin C; Clair F; Maugis E; Fermanian J; Mauvais-Jarvis P J Clin Endocrinol Metab; 1985 Mar; 60(3):575-8. PubMed ID: 3919048 [TBL] [Abstract][Full Text] [Related]
27. [Results of the GnRH-TRH and arginine-GnRH-TRH test in females with hyperprolactinemic galactorrhea]. Rudolf K; Kunkel S; Rudolf H Zentralbl Gynakol; 1987; 109(8):501-9. PubMed ID: 3111128 [TBL] [Abstract][Full Text] [Related]
28. Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease. Barbieri RL; Cooper DS; Daniels GH; Nathan D; Klibanski A; Ridgway EC Fertil Steril; 1985 Jan; 43(1):66-73. PubMed ID: 3917409 [TBL] [Abstract][Full Text] [Related]
29. Decreased prolactin responsiveness to thyrotrophin-releasing hormone and metoclopramide in hyperthyroidism. Röjdmark S; Carlsson A Acta Endocrinol (Copenh); 1985 Oct; 110(2):221-6. PubMed ID: 2998132 [TBL] [Abstract][Full Text] [Related]
30. Gradual recovery of lactotroph responsiveness to dynamic stimulation following surgical removal of prolactinomas: long-term follow-up studies. Arafah BM; Brodkey JS; Pearson OH Metabolism; 1986 Oct; 35(10):905-12. PubMed ID: 3093797 [TBL] [Abstract][Full Text] [Related]
32. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas. Arafah BM; Nekl KE; Gold RS; Selman WR J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591 [TBL] [Abstract][Full Text] [Related]
33. Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal. Moriondo P; Travaglini P; Nissim M; Conti A; Faglia G J Clin Endocrinol Metab; 1985 Apr; 60(4):764-72. PubMed ID: 3919052 [TBL] [Abstract][Full Text] [Related]
34. Catecholamines and pituitary function. VI. Effect of different dopamine doses on TRH-induced prolactin release in women with pathological hyperprolactinemia. Nicoletti I; Ambrosi F; Pagliacci MC; Pelicci G; Giammartino C; Maggio D; Fedeli L; Filipponi P Horm Metab Res; 1987 Mar; 19(3):125-9. PubMed ID: 3106177 [TBL] [Abstract][Full Text] [Related]
35. Pituitary microadenoma: diagnostic studies. Pineda G; Valdes M; Castro M; Stevenson C Clin Endocrinol (Oxf); 1979 Jun; 10(6):583-94. PubMed ID: 113146 [TBL] [Abstract][Full Text] [Related]
36. [Determination of pituitary hormones in cerebrospinal fluid in normal subjects and in hypothalamo-pituitary diseases. Secreting or non-secreting pituitary adenoma, empty sella syndrome, hypothalamic syndromes]. Turpin G; Heshmati HM; Roger M; Cesselin F; Lagoguey M; Baulieu JL; De Gennes JL Ann Endocrinol (Paris); 1980; 41(1):21-30. PubMed ID: 7396391 [TBL] [Abstract][Full Text] [Related]
37. Suppression of serum immunoreactive human epidermal growth factor by acute increase in prolactin in women. Chen CF; Kurachi H; Miyake A; Aono T; Tanizawa O Endocrinol Jpn; 1989 Apr; 36(2):203-9. PubMed ID: 2506003 [TBL] [Abstract][Full Text] [Related]